InvestorsHub Logo

Extremist223

08/15/19 4:31 AM

#239804 RE: Umibe5690 #239803

Longs may need to temper their share price appreciation expectations in exchange for a less risky route to approval.



thats not how it works.

longfellow95

08/15/19 6:11 AM

#239806 RE: Umibe5690 #239803

Longs may need to temper their share price appreciation expectations in exchange for a less risky route to approval. JMHO.



Nope. Doesn't apply to me.

longfellow95

08/15/19 6:47 AM

#239807 RE: Umibe5690 #239803

..government regulatory agencies are highly political and biased towards who "butters" their bread.



What, are you suggesting that there is an element of bias in the US drug approval system?

Surely not...

I'd rather they partnered with Huawei to ensure that their therapy has a fighting chance of reaching patients (and changing the face of cancer treatment), than by selling out to the status quo, and have this treatment filed under 'no further action'.

The FDA doesn't regulate the whole world fortunately.

This long has a long-term investment horizon.